- 2024-08-20 02:19抑制剂ZINC194100678|ZINC194100678|1995025-05-2|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:19抑制剂ZINC194100678|ZINC194100678|1995025-05-2|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:19抑制剂ZINC194100678|ZINC194100678|1995025-05-2|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:19抑制剂ZINC09659342|ZINC09659342|1668604-47-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:19抑制剂ZINC09659342|ZINC09659342|1668604-47-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:19抑制剂ZINC13466751|ZINC13466751|117953-17-0|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:19抑制剂ZINC13466751|ZINC13466751|117953-17-0|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:19抑制剂ZINC00881524|ZINC00881524|557782-81-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:19抑制剂ZINC00881524|ZINC00881524|557782-81-7|Adamas life|≥98%（以实测数值为准）|BR|500mg
- 2024-08-20 02:19抑制剂ZINC09659342|ZINC09659342|1668604-47-4|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:19抑制剂Z-IETD-FMK|Z-IETD-FMK|210344-98-2|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:19抑制剂ZINC00881524|ZINC00881524|557782-81-7|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:19抑制剂Zapnometinib|Zapnometinib|303175-44-2|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:19抑制剂Z-IETD-FMK|Z-IETD-FMK|210344-98-2|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:19抑制剂Z-IETD-FMK|Z-IETD-FMK|210344-98-2|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:19抑制剂Zapnometinib|Zapnometinib|303175-44-2|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:18抑制剂Zanzalintinib|Zanzalintinib|2367004-54-2|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:18抑制剂Zapnometinib|Zapnometinib|303175-44-2|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:18抑制剂Zabadinostat|Zabadinostat|934828-12-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:18抑制剂Zanzalintinib|Zanzalintinib|2367004-54-2|Adamas life|≥98%（以实测数值为准）|BR|1mg
